179 related articles for article (PubMed ID: 30846247)
1. A retrospective review of conjunctival melanoma: Presentation, treatment and evolution.
Pacheco GE; Garcia-Onrubia L; Garcia-Alvarez C; Muñoz MF; Garcia-Lagarto E; Perez DM; Alonso P; Saornil MA
Arch Soc Esp Oftalmol (Engl Ed); 2019 May; 94(5):218-224. PubMed ID: 30846247
[TBL] [Abstract][Full Text] [Related]
2. Primary acquired melanosis of the conjunctiva: risks for progression to melanoma in 311 eyes. The 2006 Lorenz E. Zimmerman lecture.
Shields JA; Shields CL; Mashayekhi A; Marr BP; Benavides R; Thangappan A; Phan L; Eagle RC
Ophthalmology; 2008 Mar; 115(3):511-519.e2. PubMed ID: 17884168
[TBL] [Abstract][Full Text] [Related]
3. Factors affecting recurrence and metastasis in conjunctival melanoma.
Çalış Karanfil F; Gündüz AK; Gündüz ÖÖ; Özalp Ateş FS
Int Ophthalmol; 2023 Nov; 43(11):4203-4215. PubMed ID: 37639080
[TBL] [Abstract][Full Text] [Related]
4. Conjunctival Melanoma in Asian Indians: A Study of 42 Patients.
Kaliki S; Vasanthapuram VH; Mishra DK
Semin Ophthalmol; 2019; 34(3):182-187. PubMed ID: 31135259
[No Abstract] [Full Text] [Related]
5. [Clinical findings and prognosis of 11 cases of conjunctival malignant melanoma].
Kimura K; Usui Y; Goto H
Nippon Ganka Gakkai Zasshi; 2012 May; 116(5):503-9. PubMed ID: 22690541
[TBL] [Abstract][Full Text] [Related]
6. [Treatment modalities for conjunctival melanoma].
Krause L; Mladenova A; Bechrakis NE; Kreusel KM; Plath T; Moser L; Foerster M
Klin Monbl Augenheilkd; 2009 Dec; 226(12):1012-6. PubMed ID: 20108195
[TBL] [Abstract][Full Text] [Related]
7. A Retrospective Review of Conjunctival Melanoma Presentation, Treatment, and Outcome and an Investigation of Features Associated With BRAF Mutations.
Larsen AC; Dahmcke CM; Dahl C; Siersma VD; Toft PB; Coupland SE; Prause JU; Guldberg P; Heegaard S
JAMA Ophthalmol; 2015 Nov; 133(11):1295-303. PubMed ID: 26425792
[TBL] [Abstract][Full Text] [Related]
8. [Malignant conjunctival melanoma. Clinical review with recommendations for diagnosis, therapy and follow-up].
Lommatzsch PK; Werschnik C
Klin Monbl Augenheilkd; 2002 Oct; 219(10):710-21. PubMed ID: 12447715
[TBL] [Abstract][Full Text] [Related]
9. Conjunctival malignant melanoma in Denmark: epidemiology, treatment and prognosis with special emphasis on tumorigenesis and genetic profile.
Larsen AC
Acta Ophthalmol; 2016 May; 94 Thesis 1():1-27. PubMed ID: 27192168
[TBL] [Abstract][Full Text] [Related]
10. Conjunctival melanoma in patients with xeroderma pigmentosum: a series of four cases.
Vasanthapuram VH; Kaliki S
Int Ophthalmol; 2020 May; 40(5):1143-1146. PubMed ID: 31933024
[TBL] [Abstract][Full Text] [Related]
11. Topical mitomycin chemotherapy for conjunctival malignant melanoma and primary acquired melanosis with atypia: clinical experience with histopathologic observations.
Demirci H; McCormick SA; Finger PT
Arch Ophthalmol; 2000 Jul; 118(7):885-91. PubMed ID: 10900099
[TBL] [Abstract][Full Text] [Related]
12. [Malignant melanoma of the conjunctiva].
Novais GA; Karp CL
Arq Bras Oftalmol; 2012; 75(4):289-95. PubMed ID: 23258665
[TBL] [Abstract][Full Text] [Related]
13. Malignant melanoma of the conjunctiva.
Brownstein S
Cancer Control; 2004; 11(5):310-6. PubMed ID: 15377990
[TBL] [Abstract][Full Text] [Related]
14. Pigmented conjunctival and scleral lesions.
Liesegang TJ
Mayo Clin Proc; 1994 Feb; 69(2):151-61. PubMed ID: 8309267
[TBL] [Abstract][Full Text] [Related]
15. Management of pigmented conjunctival lesions.
Oellers P; Karp CL
Ocul Surf; 2012 Oct; 10(4):251-63. PubMed ID: 23084146
[TBL] [Abstract][Full Text] [Related]
16. Conjunctival melanoma: risk factors for recurrence, exenteration, metastasis, and death in 150 consecutive patients.
Shields CL
Trans Am Ophthalmol Soc; 2000; 98():471-92. PubMed ID: 11190037
[TBL] [Abstract][Full Text] [Related]
17. Therapy of melanocytic conjunctival tumors.
Halas JM; Svetlosakova Z; Babal P
Bratisl Lek Listy; 2013; 114(8):446-50. PubMed ID: 23944618
[TBL] [Abstract][Full Text] [Related]
18. Conjunctival melanoma treatment outcomes in 288 patients: a multicentre international data-sharing study.
Jain P; Finger PT; Fili M; Damato B; Coupland SE; Heimann H; Kenawy N; J Brouwer N; Marinkovic M; Van Duinen SG; Caujolle JP; Maschi C; Seregard S; Pelayes D; Folgar M; Yousef YA; Krema H; Gallie B; Calle-Vasquez A;
Br J Ophthalmol; 2021 Oct; 105(10):1358-1364. PubMed ID: 32892167
[TBL] [Abstract][Full Text] [Related]
19. Clinical profile of melanocytic lesions of the ocular surface in a Hispanic population.
Garza-Garza LA; Ramos-Davila EM; Ruiz-Lozano RE; Gutierrez-Juarez K; Hernandez-Camarena JC
Int Ophthalmol; 2022 Sep; 42(9):2765-2772. PubMed ID: 35438422
[TBL] [Abstract][Full Text] [Related]
20. [Management of conjunctival malignant melanoma associated with primary acquired melanosis (PAM) using 0.02% mitomycin C eyedrops].
Groh MJ; Holbach LM; Kühnel B; Conway RM; Naumann GO
Ophthalmologe; 2003 Sep; 100(9):708-12. PubMed ID: 14504895
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
